McLeod HL - Search Results

1

Genetic variation determines VEGF-A plasma levels in cancer patients.

Innocenti F, Jiang C, Sibley AB, Etheridge AS, Hatch AJ, Denning S, Niedzwiecki D, Shterev ID, Lin J, Furukawa Y, Kubo M, Kindler HL, Auman JT, Venook AP, Hurwitz HI, McLeod HL, Ratain MJ, Gordan R, Nixon AB, Owzar K. Innocenti F, et al. Among authors: mcleod hl. Sci Rep. 2018 Nov 5;8(1):16332. doi: 10.1038/s41598-018-34506-4. Sci Rep. 2018. PMID: 30397360 Free PMC article.

2

The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.

Ratain MJ, Miller AA, McLeod HL, Venook AP, Egorin MJ, Schilsky RL. Ratain MJ, et al. Among authors: mcleod hl. Clin Cancer Res. 2006 Jun 1;12(11 Pt 2):3612s-6s. doi: 10.1158/1078-0432.CCR-06-9008. Clin Cancer Res. 2006. PMID: 16740794 Review.

3

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.

Auman JT, McLeod HL. Auman JT, et al. Among authors: mcleod hl. Drug Metab Rev. 2008;40(2):303-15. doi: 10.1080/03602530801952427. Drug Metab Rev. 2008. PMID: 18464047 Review.

4

Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation.

Auman JT, Church R, Lee SY, Watson MA, Fleshman JW, Mcleod HL. Auman JT, et al. Among authors: mcleod hl. Eur J Cancer. 2008 Aug;44(12):1754-60. doi: 10.1016/j.ejca.2008.05.010. Epub 2008 Jul 22. Eur J Cancer. 2008. PMID: 18653328 Free PMC article. Clinical Trial.

5

Race does not explain genetic heterogeneity in pharmacogenomic pathways.

Yen-Revollo JL, Auman JT, McLeod HL. Yen-Revollo JL, et al. Among authors: mcleod hl. Pharmacogenomics. 2008 Nov;9(11):1639-45. doi: 10.2217/14622416.9.11.1639. Pharmacogenomics. 2008. PMID: 19018720 Free PMC article.

6

Applications of genomic tools to colorectal cancer therapeutics.

Auman JT, McLeod HL. Auman JT, et al. Among authors: mcleod hl. Curr Opin Mol Ther. 2008 Dec;10(6):548-54. Curr Opin Mol Ther. 2008. PMID: 19051132 Review.

7

Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan.

Hoskins JM, Rosner GL, Ratain MJ, McLeod HL, Innocenti F. Hoskins JM, et al. Among authors: mcleod hl. Pharmacogenomics. 2009 Jul;10(7):1139-46. doi: 10.2217/pgs.09.35. Pharmacogenomics. 2009. PMID: 19604089 Free PMC article.

8

Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.

Rakhra-Burris TK, Auman JT, Deverka P, Dressler LG, Evans JP, Goldberg RM, Havener TM, Hoskins JM, Jonas DE, Long KM, Motsinger-Reif AA, Irvin WJ, Richards KL, Roederer MW, Valgus JM, Riper Mv, Vernon JA, Zamboni WC, Wagner MJ, Walko CM, Weck KE, Wiltshire T, McLeod HL. Rakhra-Burris TK, et al. Among authors: mcleod hl. Pharmacogenomics. 2010 Jan;11(1):13-21. doi: 10.2217/pgs.09.167. Pharmacogenomics. 2010. PMID: 20017668 Free article.

9

Now's the time to find biomarkers on purpose.

Auman JT, McLeod HL. Auman JT, et al. Among authors: mcleod hl. Ann Oncol. 2010 Feb;21(2):193-194. doi: 10.1093/annonc/mdp571. Epub 2010 Jan 4. Ann Oncol. 2010. PMID: 20047974 Free article. No abstract available.

10

Colorectal cancer cell lines lack the molecular heterogeneity of clinical colorectal tumors.

Auman JT, McLeod HL. Auman JT, et al. Among authors: mcleod hl. Clin Colorectal Cancer. 2010 Jan;9(1):40-7. doi: 10.3816/CCC.2010.n.005. Clin Colorectal Cancer. 2010. PMID: 20100687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

588 results

Search Page